Related Experiment Video
Updated: May 23, 2025
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Inflammatory Bowel Disease in Children: Current Diagnosis and Treatment Strategies
Akshita Bhalla1, Anushka Shahi2, Madhurima Maity3
1Internal Medicine, Punjab Institute of Medical Sciences, Jalandhar, IND.
Insights
Pediatric inflammatory bowel disease (PIBD) management is evolving with new therapies and holistic care approaches. Addressing challenges like growth issues and psychosocial needs is crucial for improving quality of life in children with PIBD.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Child Health
Background:
- Pediatric inflammatory bowel disease (PIBD), encompassing Crohn's disease and ulcerative colitis, is a growing global health concern.
- PIBD presents unique challenges in children, including impaired growth, nutritional deficits, and psychosocial difficulties, distinct from adult forms.
- Current management requires tailored strategies beyond traditional adult protocols.
Purpose of the Study:
- To review current diagnostic approaches for PIBD.
- To explore the evolution of treatment strategies, from conventional therapies to advanced biologics and novel small molecules.
- To highlight the importance of supportive and innovative treatments, as well as holistic care in PIBD management.
Main Methods:
- Literature review of diagnostic and therapeutic strategies for PIBD.
- Analysis of traditional therapies (aminosalicylates, corticosteroids, immunomodulators).
- Evaluation of emerging treatments including biologics (infliximab, adalimumab, vedolizumab, ustekinumab), JAK inhibitors, enteral nutrition, probiotics, stem cell therapy, and fecal microbiota transplant.
Main Results:
- Treatment has advanced from traditional drugs to sophisticated biologic agents and investigational small molecules.
- Supportive measures like exclusive enteral nutrition and probiotics are vital components of care.
- Innovative therapies such as stem cell therapy and fecal microbiota transplant are under investigation.
- Holistic care, including psychosocial support, significantly improves patient quality of life.
Conclusions:
- Effective PIBD management necessitates a comprehensive approach, integrating medical, nutritional, and psychosocial interventions.
- Key challenges include infection risks, lack of pediatric-specific guidelines, and limited pediatric trial participation.
- Future directions involve structured transition care, updated guidelines, and precision medicine for personalized pediatric IBD treatment.
Abstract:
Pediatric inflammatory bowel disease (PIBD), including Crohn's disease and ulcerative colitis, has emerged as a significant global health challenge with rising incidence rates. Unlike adult inflammatory bowel disease, PIBD presents complexities, including growth impairment, nutritional deficiencies, and psychosocial challenges that necessitate tailored management strategies. This article reviews current diagnostic and emerging treatment strategies to highlight the evolution from traditional therapies such as aminosalicylates, corticosteroids, and immunomodulators to advanced biologic agents like infliximab and adalimumab. Emerging biological therapies, including vedolizumab and ustekinumab, show promise, while novel small molecule therapies such as Janus kinase (JAK) inhibitors are under investigation for potential use in the pediatric population. Supportive treatments, including exclusive enteral nutrition, modified diets, and probiotics, play a critical role in comprehensive disease management. Stem cell therapy and fecal microbiota transplant represent innovative approaches still under clinical evaluation. The review underscores the significance of holistic care, incorporating mind-body interventions and psychosocial support to improve patient quality of life. Key challenges persist, such as infection risks associated with long-term biological therapy use, gaps in pediatric-specific guidelines, and the limited inclusion of children in clinical trials. Future recommendations emphasize the importance of structured transition programs bridging pediatric and adult care, regular updates to clinical guidelines, and the integration of precision medicine to personalize treatment plans. Continued research and collaboration are essential for advancing the understanding and management of PIBD, ensuring that pediatric patients benefit from the most effective, evidence-based care available.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...